nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—TOP2A—Epirubicin—ovarian cancer	0.212	0.307	CbGbCtD
Norfloxacin—TOP2A—Doxorubicin—ovarian cancer	0.113	0.163	CbGbCtD
Norfloxacin—CYP3A7—Paclitaxel—ovarian cancer	0.0573	0.0828	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0573	0.0828	CbGbCtD
Norfloxacin—CYP3A5—Paclitaxel—ovarian cancer	0.043	0.0621	CbGbCtD
Norfloxacin—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0414	0.0599	CbGbCtD
Norfloxacin—CYP3A7—Docetaxel—ovarian cancer	0.0414	0.0599	CbGbCtD
Norfloxacin—CYP3A4—Topotecan—ovarian cancer	0.0338	0.0489	CbGbCtD
Norfloxacin—CYP3A5—Docetaxel—ovarian cancer	0.0311	0.0449	CbGbCtD
Norfloxacin—CYP3A4—Vinorelbine—ovarian cancer	0.0238	0.0345	CbGbCtD
Norfloxacin—CYP3A4—Paclitaxel—ovarian cancer	0.0167	0.0242	CbGbCtD
Norfloxacin—CYP3A4—Docetaxel—ovarian cancer	0.0121	0.0175	CbGbCtD
Norfloxacin—CYP3A4—Doxorubicin—ovarian cancer	0.00903	0.0131	CbGbCtD
Norfloxacin—TOP2A—Docetaxel—Paclitaxel—ovarian cancer	0.0017	0.219	CbGdCrCtD
Norfloxacin—TOP2A—Irinotecan—Topotecan—ovarian cancer	0.00145	0.187	CbGdCrCtD
Norfloxacin—TOP2A—myometrium—ovarian cancer	0.00116	0.0805	CbGeAlD
Norfloxacin—TOP2A—Vindesine—Vinorelbine—ovarian cancer	0.00108	0.139	CbGdCrCtD
Norfloxacin—TOP2A—uterine cervix—ovarian cancer	0.000901	0.0626	CbGeAlD
Norfloxacin—TOP2A—decidua—ovarian cancer	0.000858	0.0597	CbGeAlD
Norfloxacin—TOP2A—Paclitaxel—Docetaxel—ovarian cancer	0.000848	0.109	CbGdCrCtD
Norfloxacin—TOP2A—endometrium—ovarian cancer	0.000815	0.0566	CbGeAlD
Norfloxacin—TOP2A—uterus—ovarian cancer	0.000751	0.0522	CbGeAlD
Norfloxacin—TOP2A—bone marrow—ovarian cancer	0.000637	0.0443	CbGeAlD
Norfloxacin—TOP2A—female gonad—ovarian cancer	0.000614	0.0427	CbGeAlD
Norfloxacin—SLC22A5—myometrium—ovarian cancer	0.000613	0.0426	CbGeAlD
Norfloxacin—TOP2A—vagina—ovarian cancer	0.00061	0.0424	CbGeAlD
Norfloxacin—TOP2A—Vincristine—Vinorelbine—ovarian cancer	0.000583	0.075	CbGdCrCtD
Norfloxacin—CYP2A6—vagina—ovarian cancer	0.000557	0.0388	CbGeAlD
Norfloxacin—TOP2A—testis—ovarian cancer	0.000545	0.0379	CbGeAlD
Norfloxacin—SLC22A5—uterine cervix—ovarian cancer	0.000477	0.0332	CbGeAlD
Norfloxacin—TOP2A—Vinblastine—Vinorelbine—ovarian cancer	0.000469	0.0603	CbGdCrCtD
Norfloxacin—SLC22A5—endometrium—ovarian cancer	0.000431	0.03	CbGeAlD
Norfloxacin—CYP1A1—epithelium—ovarian cancer	0.00043	0.0299	CbGeAlD
Norfloxacin—CYP1A1—uterine cervix—ovarian cancer	0.000426	0.0296	CbGeAlD
Norfloxacin—CYP3A5—uterine cervix—ovarian cancer	0.000417	0.029	CbGeAlD
Norfloxacin—TOP2A—lymph node—ovarian cancer	0.000395	0.0274	CbGeAlD
Norfloxacin—SLC22A5—female reproductive system—ovarian cancer	0.000357	0.0248	CbGeAlD
Norfloxacin—CYP1A1—uterus—ovarian cancer	0.000355	0.0247	CbGeAlD
Norfloxacin—SLC22A5—female gonad—ovarian cancer	0.000325	0.0226	CbGeAlD
Norfloxacin—SLC22A5—vagina—ovarian cancer	0.000323	0.0225	CbGeAlD
Norfloxacin—CYP1A1—female reproductive system—ovarian cancer	0.000319	0.0222	CbGeAlD
Norfloxacin—CYP1A1—female gonad—ovarian cancer	0.000291	0.0202	CbGeAlD
Norfloxacin—CYP1A1—vagina—ovarian cancer	0.000289	0.0201	CbGeAlD
Norfloxacin—SLC22A5—testis—ovarian cancer	0.000288	0.0201	CbGeAlD
Norfloxacin—Anaphylactoid reaction—Doxorubicin—ovarian cancer	0.000286	0.00115	CcSEcCtD
Norfloxacin—Vomiting—Topotecan—ovarian cancer	0.000284	0.00115	CcSEcCtD
Norfloxacin—CYP3A5—female gonad—ovarian cancer	0.000284	0.0198	CbGeAlD
Norfloxacin—TOP2A—Idarubicin—Epirubicin—ovarian cancer	0.000284	0.0365	CbGdCrCtD
Norfloxacin—TOP2A—Doxorubicin—Epirubicin—ovarian cancer	0.000284	0.0365	CbGdCrCtD
Norfloxacin—TOP2A—Daunorubicin—Epirubicin—ovarian cancer	0.000284	0.0365	CbGdCrCtD
Norfloxacin—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000284	0.00114	CcSEcCtD
Norfloxacin—Vertigo—Paclitaxel—ovarian cancer	0.000283	0.00114	CcSEcCtD
Norfloxacin—CYP3A5—vagina—ovarian cancer	0.000282	0.0196	CbGeAlD
Norfloxacin—Leukopenia—Paclitaxel—ovarian cancer	0.000282	0.00114	CcSEcCtD
Norfloxacin—Rash—Topotecan—ovarian cancer	0.000282	0.00114	CcSEcCtD
Norfloxacin—Hypersensitivity—Vinorelbine—ovarian cancer	0.000282	0.00114	CcSEcCtD
Norfloxacin—Dermatitis—Topotecan—ovarian cancer	0.000282	0.00114	CcSEcCtD
Norfloxacin—Ataxia—Epirubicin—ovarian cancer	0.000282	0.00113	CcSEcCtD
Norfloxacin—Blood creatinine increased—Epirubicin—ovarian cancer	0.000281	0.00113	CcSEcCtD
Norfloxacin—Headache—Topotecan—ovarian cancer	0.00028	0.00113	CcSEcCtD
Norfloxacin—Palpitations—Paclitaxel—ovarian cancer	0.000279	0.00112	CcSEcCtD
Norfloxacin—Vomiting—Melphalan—ovarian cancer	0.000279	0.00112	CcSEcCtD
Norfloxacin—Diplopia—Doxorubicin—ovarian cancer	0.000277	0.00112	CcSEcCtD
Norfloxacin—Osteoarthritis—Doxorubicin—ovarian cancer	0.000277	0.00112	CcSEcCtD
Norfloxacin—Liver function test abnormal—Epirubicin—ovarian cancer	0.000276	0.00111	CcSEcCtD
Norfloxacin—Rash—Melphalan—ovarian cancer	0.000276	0.00111	CcSEcCtD
Norfloxacin—Dermatitis—Melphalan—ovarian cancer	0.000276	0.00111	CcSEcCtD
Norfloxacin—Chills—Docetaxel—ovarian cancer	0.000276	0.00111	CcSEcCtD
Norfloxacin—Asthenia—Vinorelbine—ovarian cancer	0.000275	0.00111	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Epirubicin—ovarian cancer	0.000274	0.0011	CcSEcCtD
Norfloxacin—Convulsion—Paclitaxel—ovarian cancer	0.000273	0.0011	CcSEcCtD
Norfloxacin—Pruritus—Vinorelbine—ovarian cancer	0.000271	0.00109	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.00027	0.00109	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Epirubicin—ovarian cancer	0.00027	0.00109	CcSEcCtD
Norfloxacin—Chest pain—Paclitaxel—ovarian cancer	0.000269	0.00108	CcSEcCtD
Norfloxacin—Arthralgia—Paclitaxel—ovarian cancer	0.000269	0.00108	CcSEcCtD
Norfloxacin—Myalgia—Paclitaxel—ovarian cancer	0.000269	0.00108	CcSEcCtD
Norfloxacin—Anxiety—Paclitaxel—ovarian cancer	0.000268	0.00108	CcSEcCtD
Norfloxacin—Erythema—Docetaxel—ovarian cancer	0.000267	0.00108	CcSEcCtD
Norfloxacin—Nausea—Topotecan—ovarian cancer	0.000266	0.00107	CcSEcCtD
Norfloxacin—TOP2A—Epirubicin—Doxorubicin—ovarian cancer	0.000263	0.0338	CbGdCrCtD
Norfloxacin—TOP2A—Idarubicin—Doxorubicin—ovarian cancer	0.000263	0.0338	CbGdCrCtD
Norfloxacin—TOP2A—Daunorubicin—Doxorubicin—ovarian cancer	0.000263	0.0338	CbGdCrCtD
Norfloxacin—Dry mouth—Paclitaxel—ovarian cancer	0.000263	0.00106	CcSEcCtD
Norfloxacin—Diarrhoea—Vinorelbine—ovarian cancer	0.000262	0.00105	CcSEcCtD
Norfloxacin—Dysgeusia—Docetaxel—ovarian cancer	0.000262	0.00105	CcSEcCtD
Norfloxacin—Ataxia—Doxorubicin—ovarian cancer	0.000261	0.00105	CcSEcCtD
Norfloxacin—Nausea—Melphalan—ovarian cancer	0.00026	0.00105	CcSEcCtD
Norfloxacin—Confusional state—Paclitaxel—ovarian cancer	0.00026	0.00105	CcSEcCtD
Norfloxacin—Blood creatinine increased—Doxorubicin—ovarian cancer	0.00026	0.00105	CcSEcCtD
Norfloxacin—Dysphagia—Epirubicin—ovarian cancer	0.000259	0.00104	CcSEcCtD
Norfloxacin—Back pain—Docetaxel—ovarian cancer	0.000259	0.00104	CcSEcCtD
Norfloxacin—Oedema—Paclitaxel—ovarian cancer	0.000257	0.00104	CcSEcCtD
Norfloxacin—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000257	0.00104	CcSEcCtD
Norfloxacin—Muscle spasms—Docetaxel—ovarian cancer	0.000257	0.00104	CcSEcCtD
Norfloxacin—Eosinophilia—Epirubicin—ovarian cancer	0.000256	0.00103	CcSEcCtD
Norfloxacin—Liver function test abnormal—Doxorubicin—ovarian cancer	0.000256	0.00103	CcSEcCtD
Norfloxacin—Pancreatitis—Epirubicin—ovarian cancer	0.000254	0.00102	CcSEcCtD
Norfloxacin—Dizziness—Vinorelbine—ovarian cancer	0.000253	0.00102	CcSEcCtD
Norfloxacin—Orthostatic hypotension—Doxorubicin—ovarian cancer	0.000253	0.00102	CcSEcCtD
Norfloxacin—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000252	0.00102	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.00025	0.00101	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Doxorubicin—ovarian cancer	0.00025	0.00101	CcSEcCtD
Norfloxacin—Hyperhidrosis—Paclitaxel—ovarian cancer	0.000249	0.001	CcSEcCtD
Norfloxacin—Anorexia—Paclitaxel—ovarian cancer	0.000245	0.000988	CcSEcCtD
Norfloxacin—Vomiting—Vinorelbine—ovarian cancer	0.000243	0.00098	CcSEcCtD
Norfloxacin—Neutropenia—Epirubicin—ovarian cancer	0.000242	0.000975	CcSEcCtD
Norfloxacin—Rash—Vinorelbine—ovarian cancer	0.000241	0.000972	CcSEcCtD
Norfloxacin—Dermatitis—Vinorelbine—ovarian cancer	0.000241	0.000971	CcSEcCtD
Norfloxacin—Headache—Vinorelbine—ovarian cancer	0.00024	0.000966	CcSEcCtD
Norfloxacin—Dysphagia—Doxorubicin—ovarian cancer	0.000239	0.000965	CcSEcCtD
Norfloxacin—Leukopenia—Docetaxel—ovarian cancer	0.000239	0.000964	CcSEcCtD
Norfloxacin—Eosinophilia—Doxorubicin—ovarian cancer	0.000237	0.000955	CcSEcCtD
Norfloxacin—Palpitations—Docetaxel—ovarian cancer	0.000236	0.000952	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000236	0.000952	CcSEcCtD
Norfloxacin—Pancreatitis—Doxorubicin—ovarian cancer	0.000235	0.000946	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000235	0.000945	CcSEcCtD
Norfloxacin—CYP3A4—female reproductive system—ovarian cancer	0.000234	0.0163	CbGeAlD
Norfloxacin—Insomnia—Paclitaxel—ovarian cancer	0.000233	0.000938	CcSEcCtD
Norfloxacin—Convulsion—Docetaxel—ovarian cancer	0.000232	0.000933	CcSEcCtD
Norfloxacin—Paraesthesia—Paclitaxel—ovarian cancer	0.000231	0.000931	CcSEcCtD
Norfloxacin—Drowsiness—Epirubicin—ovarian cancer	0.000231	0.00093	CcSEcCtD
Norfloxacin—Dyspnoea—Paclitaxel—ovarian cancer	0.00023	0.000925	CcSEcCtD
Norfloxacin—Somnolence—Paclitaxel—ovarian cancer	0.000229	0.000922	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000229	0.000922	CcSEcCtD
Norfloxacin—Myalgia—Docetaxel—ovarian cancer	0.000228	0.000917	CcSEcCtD
Norfloxacin—Arthralgia—Docetaxel—ovarian cancer	0.000228	0.000917	CcSEcCtD
Norfloxacin—Chest pain—Docetaxel—ovarian cancer	0.000228	0.000917	CcSEcCtD
Norfloxacin—Nausea—Vinorelbine—ovarian cancer	0.000227	0.000916	CcSEcCtD
Norfloxacin—Renal failure—Epirubicin—ovarian cancer	0.000227	0.000914	CcSEcCtD
Norfloxacin—Dyspepsia—Paclitaxel—ovarian cancer	0.000227	0.000913	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000226	0.000911	CcSEcCtD
Norfloxacin—Stomatitis—Epirubicin—ovarian cancer	0.000225	0.000906	CcSEcCtD
Norfloxacin—Jaundice—Epirubicin—ovarian cancer	0.000225	0.000906	CcSEcCtD
Norfloxacin—Conjunctivitis—Epirubicin—ovarian cancer	0.000224	0.000904	CcSEcCtD
Norfloxacin—Neutropenia—Doxorubicin—ovarian cancer	0.000224	0.000902	CcSEcCtD
Norfloxacin—Decreased appetite—Paclitaxel—ovarian cancer	0.000224	0.000901	CcSEcCtD
Norfloxacin—Dry mouth—Docetaxel—ovarian cancer	0.000223	0.000897	CcSEcCtD
Norfloxacin—Fatigue—Paclitaxel—ovarian cancer	0.000222	0.000894	CcSEcCtD
Norfloxacin—Constipation—Paclitaxel—ovarian cancer	0.00022	0.000887	CcSEcCtD
Norfloxacin—Haematuria—Epirubicin—ovarian cancer	0.00022	0.000886	CcSEcCtD
Norfloxacin—Confusional state—Docetaxel—ovarian cancer	0.00022	0.000886	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000219	0.000881	CcSEcCtD
Norfloxacin—Anaphylactic shock—Docetaxel—ovarian cancer	0.000218	0.000879	CcSEcCtD
Norfloxacin—Oedema—Docetaxel—ovarian cancer	0.000218	0.000879	CcSEcCtD
Norfloxacin—Agranulocytosis—Epirubicin—ovarian cancer	0.000215	0.000867	CcSEcCtD
Norfloxacin—Thrombocytopenia—Docetaxel—ovarian cancer	0.000214	0.000861	CcSEcCtD
Norfloxacin—Drowsiness—Doxorubicin—ovarian cancer	0.000214	0.00086	CcSEcCtD
Norfloxacin—Feeling abnormal—Paclitaxel—ovarian cancer	0.000212	0.000855	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000212	0.000853	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000211	0.000848	CcSEcCtD
Norfloxacin—Renal failure—Doxorubicin—ovarian cancer	0.00021	0.000845	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000209	0.000843	CcSEcCtD
Norfloxacin—SLC22A5—lymph node—ovarian cancer	0.000209	0.0145	CbGeAlD
Norfloxacin—Stomatitis—Doxorubicin—ovarian cancer	0.000208	0.000838	CcSEcCtD
Norfloxacin—Jaundice—Doxorubicin—ovarian cancer	0.000208	0.000838	CcSEcCtD
Norfloxacin—Anorexia—Docetaxel—ovarian cancer	0.000208	0.000838	CcSEcCtD
Norfloxacin—Conjunctivitis—Doxorubicin—ovarian cancer	0.000208	0.000836	CcSEcCtD
Norfloxacin—Hepatitis—Epirubicin—ovarian cancer	0.000207	0.000834	CcSEcCtD
Norfloxacin—Hypoaesthesia—Epirubicin—ovarian cancer	0.000206	0.00083	CcSEcCtD
Norfloxacin—Urticaria—Paclitaxel—ovarian cancer	0.000205	0.000824	CcSEcCtD
Norfloxacin—Haematuria—Doxorubicin—ovarian cancer	0.000204	0.00082	CcSEcCtD
Norfloxacin—Body temperature increased—Paclitaxel—ovarian cancer	0.000204	0.00082	CcSEcCtD
Norfloxacin—Abdominal pain—Paclitaxel—ovarian cancer	0.000204	0.00082	CcSEcCtD
Norfloxacin—Visual impairment—Epirubicin—ovarian cancer	0.0002	0.000804	CcSEcCtD
Norfloxacin—Agranulocytosis—Doxorubicin—ovarian cancer	0.000199	0.000803	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.000199	0.000801	CcSEcCtD
Norfloxacin—Insomnia—Docetaxel—ovarian cancer	0.000197	0.000795	CcSEcCtD
Norfloxacin—Paraesthesia—Docetaxel—ovarian cancer	0.000196	0.000789	CcSEcCtD
Norfloxacin—Erythema multiforme—Epirubicin—ovarian cancer	0.000196	0.000789	CcSEcCtD
Norfloxacin—Dyspnoea—Docetaxel—ovarian cancer	0.000195	0.000784	CcSEcCtD
Norfloxacin—Somnolence—Docetaxel—ovarian cancer	0.000194	0.000781	CcSEcCtD
Norfloxacin—Tinnitus—Epirubicin—ovarian cancer	0.000193	0.000778	CcSEcCtD
Norfloxacin—Dyspepsia—Docetaxel—ovarian cancer	0.000192	0.000774	CcSEcCtD
Norfloxacin—Hepatitis—Doxorubicin—ovarian cancer	0.000192	0.000772	CcSEcCtD
Norfloxacin—Hypoaesthesia—Doxorubicin—ovarian cancer	0.000191	0.000768	CcSEcCtD
Norfloxacin—Decreased appetite—Docetaxel—ovarian cancer	0.00019	0.000764	CcSEcCtD
Norfloxacin—Hypersensitivity—Paclitaxel—ovarian cancer	0.00019	0.000764	CcSEcCtD
Norfloxacin—Fatigue—Docetaxel—ovarian cancer	0.000188	0.000758	CcSEcCtD
Norfloxacin—CYP1A1—lymph node—ovarian cancer	0.000187	0.013	CbGeAlD
Norfloxacin—Constipation—Docetaxel—ovarian cancer	0.000187	0.000752	CcSEcCtD
Norfloxacin—Chills—Epirubicin—ovarian cancer	0.000186	0.000749	CcSEcCtD
Norfloxacin—Visual impairment—Doxorubicin—ovarian cancer	0.000185	0.000744	CcSEcCtD
Norfloxacin—Asthenia—Paclitaxel—ovarian cancer	0.000185	0.000744	CcSEcCtD
Norfloxacin—Pruritus—Paclitaxel—ovarian cancer	0.000182	0.000734	CcSEcCtD
Norfloxacin—Erythema multiforme—Doxorubicin—ovarian cancer	0.000181	0.00073	CcSEcCtD
Norfloxacin—Erythema—Epirubicin—ovarian cancer	0.00018	0.000726	CcSEcCtD
Norfloxacin—Feeling abnormal—Docetaxel—ovarian cancer	0.00018	0.000724	CcSEcCtD
Norfloxacin—Tinnitus—Doxorubicin—ovarian cancer	0.000179	0.00072	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000178	0.000719	CcSEcCtD
Norfloxacin—Flatulence—Epirubicin—ovarian cancer	0.000178	0.000716	CcSEcCtD
Norfloxacin—Tension—Epirubicin—ovarian cancer	0.000177	0.000713	CcSEcCtD
Norfloxacin—Dysgeusia—Epirubicin—ovarian cancer	0.000177	0.000711	CcSEcCtD
Norfloxacin—Diarrhoea—Paclitaxel—ovarian cancer	0.000176	0.00071	CcSEcCtD
Norfloxacin—Nervousness—Epirubicin—ovarian cancer	0.000175	0.000706	CcSEcCtD
Norfloxacin—Back pain—Epirubicin—ovarian cancer	0.000174	0.000703	CcSEcCtD
Norfloxacin—Muscle spasms—Epirubicin—ovarian cancer	0.000173	0.000698	CcSEcCtD
Norfloxacin—Abdominal pain—Docetaxel—ovarian cancer	0.000173	0.000695	CcSEcCtD
Norfloxacin—Body temperature increased—Docetaxel—ovarian cancer	0.000173	0.000695	CcSEcCtD
Norfloxacin—Chills—Doxorubicin—ovarian cancer	0.000172	0.000693	CcSEcCtD
Norfloxacin—Dizziness—Paclitaxel—ovarian cancer	0.00017	0.000686	CcSEcCtD
Norfloxacin—Vision blurred—Epirubicin—ovarian cancer	0.00017	0.000685	CcSEcCtD
Norfloxacin—Erythema—Doxorubicin—ovarian cancer	0.000167	0.000672	CcSEcCtD
Norfloxacin—Agitation—Epirubicin—ovarian cancer	0.000166	0.000668	CcSEcCtD
Norfloxacin—Flatulence—Doxorubicin—ovarian cancer	0.000164	0.000662	CcSEcCtD
Norfloxacin—Tension—Doxorubicin—ovarian cancer	0.000164	0.00066	CcSEcCtD
Norfloxacin—Vomiting—Paclitaxel—ovarian cancer	0.000164	0.000659	CcSEcCtD
Norfloxacin—Dysgeusia—Doxorubicin—ovarian cancer	0.000163	0.000658	CcSEcCtD
Norfloxacin—Rash—Paclitaxel—ovarian cancer	0.000162	0.000654	CcSEcCtD
Norfloxacin—Dermatitis—Paclitaxel—ovarian cancer	0.000162	0.000653	CcSEcCtD
Norfloxacin—Nervousness—Doxorubicin—ovarian cancer	0.000162	0.000653	CcSEcCtD
Norfloxacin—Vertigo—Epirubicin—ovarian cancer	0.000162	0.000653	CcSEcCtD
Norfloxacin—Leukopenia—Epirubicin—ovarian cancer	0.000161	0.00065	CcSEcCtD
Norfloxacin—Back pain—Doxorubicin—ovarian cancer	0.000161	0.00065	CcSEcCtD
Norfloxacin—Headache—Paclitaxel—ovarian cancer	0.000161	0.00065	CcSEcCtD
Norfloxacin—Hypersensitivity—Docetaxel—ovarian cancer	0.000161	0.000648	CcSEcCtD
Norfloxacin—Muscle spasms—Doxorubicin—ovarian cancer	0.00016	0.000646	CcSEcCtD
Norfloxacin—Palpitations—Epirubicin—ovarian cancer	0.000159	0.000642	CcSEcCtD
Norfloxacin—Vision blurred—Doxorubicin—ovarian cancer	0.000157	0.000633	CcSEcCtD
Norfloxacin—Asthenia—Docetaxel—ovarian cancer	0.000157	0.000631	CcSEcCtD
Norfloxacin—Convulsion—Epirubicin—ovarian cancer	0.000156	0.000629	CcSEcCtD
Norfloxacin—Pruritus—Docetaxel—ovarian cancer	0.000154	0.000622	CcSEcCtD
Norfloxacin—Arthralgia—Epirubicin—ovarian cancer	0.000154	0.000618	CcSEcCtD
Norfloxacin—Chest pain—Epirubicin—ovarian cancer	0.000154	0.000618	CcSEcCtD
Norfloxacin—Myalgia—Epirubicin—ovarian cancer	0.000154	0.000618	CcSEcCtD
Norfloxacin—Agitation—Doxorubicin—ovarian cancer	0.000153	0.000618	CcSEcCtD
Norfloxacin—Anxiety—Epirubicin—ovarian cancer	0.000153	0.000616	CcSEcCtD
Norfloxacin—Nausea—Paclitaxel—ovarian cancer	0.000153	0.000616	CcSEcCtD
Norfloxacin—Dry mouth—Epirubicin—ovarian cancer	0.00015	0.000605	CcSEcCtD
Norfloxacin—Vertigo—Doxorubicin—ovarian cancer	0.00015	0.000604	CcSEcCtD
Norfloxacin—Leukopenia—Doxorubicin—ovarian cancer	0.000149	0.000602	CcSEcCtD
Norfloxacin—Diarrhoea—Docetaxel—ovarian cancer	0.000149	0.000601	CcSEcCtD
Norfloxacin—Confusional state—Epirubicin—ovarian cancer	0.000148	0.000598	CcSEcCtD
Norfloxacin—Palpitations—Doxorubicin—ovarian cancer	0.000147	0.000594	CcSEcCtD
Norfloxacin—Anaphylactic shock—Epirubicin—ovarian cancer	0.000147	0.000593	CcSEcCtD
Norfloxacin—Oedema—Epirubicin—ovarian cancer	0.000147	0.000593	CcSEcCtD
Norfloxacin—Convulsion—Doxorubicin—ovarian cancer	0.000145	0.000582	CcSEcCtD
Norfloxacin—Dizziness—Docetaxel—ovarian cancer	0.000144	0.000581	CcSEcCtD
Norfloxacin—Thrombocytopenia—Epirubicin—ovarian cancer	0.000144	0.00058	CcSEcCtD
Norfloxacin—Hyperhidrosis—Epirubicin—ovarian cancer	0.000142	0.000573	CcSEcCtD
Norfloxacin—Myalgia—Doxorubicin—ovarian cancer	0.000142	0.000572	CcSEcCtD
Norfloxacin—Chest pain—Doxorubicin—ovarian cancer	0.000142	0.000572	CcSEcCtD
Norfloxacin—Arthralgia—Doxorubicin—ovarian cancer	0.000142	0.000572	CcSEcCtD
Norfloxacin—Anxiety—Doxorubicin—ovarian cancer	0.000142	0.00057	CcSEcCtD
Norfloxacin—Anorexia—Epirubicin—ovarian cancer	0.00014	0.000565	CcSEcCtD
Norfloxacin—Dry mouth—Doxorubicin—ovarian cancer	0.000139	0.00056	CcSEcCtD
Norfloxacin—Vomiting—Docetaxel—ovarian cancer	0.000139	0.000559	CcSEcCtD
Norfloxacin—Rash—Docetaxel—ovarian cancer	0.000138	0.000554	CcSEcCtD
Norfloxacin—Dermatitis—Docetaxel—ovarian cancer	0.000137	0.000554	CcSEcCtD
Norfloxacin—Confusional state—Doxorubicin—ovarian cancer	0.000137	0.000553	CcSEcCtD
Norfloxacin—Headache—Docetaxel—ovarian cancer	0.000137	0.000551	CcSEcCtD
Norfloxacin—Anaphylactic shock—Doxorubicin—ovarian cancer	0.000136	0.000549	CcSEcCtD
Norfloxacin—Oedema—Doxorubicin—ovarian cancer	0.000136	0.000549	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000134	0.00054	CcSEcCtD
Norfloxacin—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000133	0.000537	CcSEcCtD
Norfloxacin—Insomnia—Epirubicin—ovarian cancer	0.000133	0.000536	CcSEcCtD
Norfloxacin—Paraesthesia—Epirubicin—ovarian cancer	0.000132	0.000532	CcSEcCtD
Norfloxacin—Hyperhidrosis—Doxorubicin—ovarian cancer	0.000132	0.00053	CcSEcCtD
Norfloxacin—Dyspnoea—Epirubicin—ovarian cancer	0.000131	0.000529	CcSEcCtD
Norfloxacin—Somnolence—Epirubicin—ovarian cancer	0.000131	0.000527	CcSEcCtD
Norfloxacin—Anorexia—Doxorubicin—ovarian cancer	0.00013	0.000523	CcSEcCtD
Norfloxacin—Nausea—Docetaxel—ovarian cancer	0.00013	0.000522	CcSEcCtD
Norfloxacin—Dyspepsia—Epirubicin—ovarian cancer	0.00013	0.000522	CcSEcCtD
Norfloxacin—Decreased appetite—Epirubicin—ovarian cancer	0.000128	0.000515	CcSEcCtD
Norfloxacin—Fatigue—Epirubicin—ovarian cancer	0.000127	0.000511	CcSEcCtD
Norfloxacin—Constipation—Epirubicin—ovarian cancer	0.000126	0.000507	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000124	0.0005	CcSEcCtD
Norfloxacin—Insomnia—Doxorubicin—ovarian cancer	0.000123	0.000496	CcSEcCtD
Norfloxacin—Paraesthesia—Doxorubicin—ovarian cancer	0.000122	0.000493	CcSEcCtD
Norfloxacin—Dyspnoea—Doxorubicin—ovarian cancer	0.000121	0.000489	CcSEcCtD
Norfloxacin—Feeling abnormal—Epirubicin—ovarian cancer	0.000121	0.000489	CcSEcCtD
Norfloxacin—Somnolence—Doxorubicin—ovarian cancer	0.000121	0.000488	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Epirubicin—ovarian cancer	0.00012	0.000485	CcSEcCtD
Norfloxacin—TOP2A—Circadian rythm related genes—TYMS—ovarian cancer	0.00012	0.00315	CbGpPWpGaD
Norfloxacin—Dyspepsia—Doxorubicin—ovarian cancer	0.00012	0.000483	CcSEcCtD
Norfloxacin—CYP1A2—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.000119	0.00311	CbGpPWpGaD
Norfloxacin—Decreased appetite—Doxorubicin—ovarian cancer	0.000118	0.000477	CcSEcCtD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—ovarian cancer	0.000118	0.0031	CbGpPWpGaD
Norfloxacin—Fatigue—Doxorubicin—ovarian cancer	0.000117	0.000473	CcSEcCtD
Norfloxacin—Urticaria—Epirubicin—ovarian cancer	0.000117	0.000471	CcSEcCtD
Norfloxacin—Constipation—Doxorubicin—ovarian cancer	0.000116	0.000469	CcSEcCtD
Norfloxacin—Abdominal pain—Epirubicin—ovarian cancer	0.000116	0.000469	CcSEcCtD
Norfloxacin—Body temperature increased—Epirubicin—ovarian cancer	0.000116	0.000469	CcSEcCtD
Norfloxacin—CYP2A6—NRF2 pathway—SLC5A5—ovarian cancer	0.000114	0.003	CbGpPWpGaD
Norfloxacin—Feeling abnormal—Doxorubicin—ovarian cancer	0.000112	0.000452	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000111	0.000449	CcSEcCtD
Norfloxacin—CYP2A6—NRF2 pathway—SLC2A1—ovarian cancer	0.000111	0.0029	CbGpPWpGaD
Norfloxacin—Hypersensitivity—Epirubicin—ovarian cancer	0.000108	0.000437	CcSEcCtD
Norfloxacin—Urticaria—Doxorubicin—ovarian cancer	0.000108	0.000436	CcSEcCtD
Norfloxacin—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000108	0.00283	CbGpPWpGaD
Norfloxacin—Body temperature increased—Doxorubicin—ovarian cancer	0.000108	0.000434	CcSEcCtD
Norfloxacin—Abdominal pain—Doxorubicin—ovarian cancer	0.000108	0.000434	CcSEcCtD
Norfloxacin—Asthenia—Epirubicin—ovarian cancer	0.000106	0.000425	CcSEcCtD
Norfloxacin—Pruritus—Epirubicin—ovarian cancer	0.000104	0.000419	CcSEcCtD
Norfloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000103	0.00269	CbGpPWpGaD
Norfloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000103	0.00269	CbGpPWpGaD
Norfloxacin—CYP3A7—Biological oxidations—CYP1B1—ovarian cancer	0.000101	0.00266	CbGpPWpGaD
Norfloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.000101	0.00266	CbGpPWpGaD
Norfloxacin—Diarrhoea—Epirubicin—ovarian cancer	0.000101	0.000406	CcSEcCtD
Norfloxacin—Hypersensitivity—Doxorubicin—ovarian cancer	0.0001	0.000404	CcSEcCtD
Norfloxacin—CYP3A7—Metapathway biotransformation—CYP1B1—ovarian cancer	0.0001	0.00262	CbGpPWpGaD
Norfloxacin—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	9.79e-05	0.00257	CbGpPWpGaD
Norfloxacin—Asthenia—Doxorubicin—ovarian cancer	9.77e-05	0.000394	CcSEcCtD
Norfloxacin—Dizziness—Epirubicin—ovarian cancer	9.73e-05	0.000392	CcSEcCtD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	9.7e-05	0.00255	CbGpPWpGaD
Norfloxacin—Pruritus—Doxorubicin—ovarian cancer	9.64e-05	0.000388	CcSEcCtD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—TUBB3—ovarian cancer	9.51e-05	0.0025	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—AQP3—ovarian cancer	9.47e-05	0.00249	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—ovarian cancer	9.47e-05	0.00248	CbGpPWpGaD
Norfloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	9.43e-05	0.00247	CbGpPWpGaD
Norfloxacin—Vomiting—Epirubicin—ovarian cancer	9.36e-05	0.000377	CcSEcCtD
Norfloxacin—CYP2A6—Fluoropyrimidine Activity—TP53—ovarian cancer	9.34e-05	0.00245	CbGpPWpGaD
Norfloxacin—Diarrhoea—Doxorubicin—ovarian cancer	9.32e-05	0.000375	CcSEcCtD
Norfloxacin—CYP2A6—Biological oxidations—CYP1B1—ovarian cancer	9.3e-05	0.00244	CbGpPWpGaD
Norfloxacin—Rash—Epirubicin—ovarian cancer	9.28e-05	0.000374	CcSEcCtD
Norfloxacin—Dermatitis—Epirubicin—ovarian cancer	9.27e-05	0.000373	CcSEcCtD
Norfloxacin—Headache—Epirubicin—ovarian cancer	9.22e-05	0.000371	CcSEcCtD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—SKP2—ovarian cancer	9.18e-05	0.00241	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	9.17e-05	0.00241	CbGpPWpGaD
Norfloxacin—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	9.11e-05	0.00239	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—ATP7B—ovarian cancer	9.08e-05	0.00238	CbGpPWpGaD
Norfloxacin—Dizziness—Doxorubicin—ovarian cancer	9.01e-05	0.000363	CcSEcCtD
Norfloxacin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—ovarian cancer	9e-05	0.00236	CbGpPWpGaD
Norfloxacin—Nausea—Epirubicin—ovarian cancer	8.74e-05	0.000352	CcSEcCtD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—ovarian cancer	8.71e-05	0.00228	CbGpPWpGaD
Norfloxacin—Vomiting—Doxorubicin—ovarian cancer	8.66e-05	0.000349	CcSEcCtD
Norfloxacin—Rash—Doxorubicin—ovarian cancer	8.59e-05	0.000346	CcSEcCtD
Norfloxacin—Dermatitis—Doxorubicin—ovarian cancer	8.58e-05	0.000346	CcSEcCtD
Norfloxacin—Headache—Doxorubicin—ovarian cancer	8.53e-05	0.000344	CcSEcCtD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	8.49e-05	0.00223	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	8.49e-05	0.00223	CbGpPWpGaD
Norfloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	8.32e-05	0.00218	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	8.31e-05	0.00218	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—ovarian cancer	8.31e-05	0.00218	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MLH1—ovarian cancer	8.3e-05	0.00218	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—SKP2—ovarian cancer	8.21e-05	0.00215	CbGpPWpGaD
Norfloxacin—Nausea—Doxorubicin—ovarian cancer	8.09e-05	0.000326	CcSEcCtD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—ovarian cancer	7.97e-05	0.00209	CbGpPWpGaD
Norfloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	7.92e-05	0.00208	CbGpPWpGaD
Norfloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	7.81e-05	0.00205	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—ovarian cancer	7.78e-05	0.00204	CbGpPWpGaD
Norfloxacin—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—FASN—ovarian cancer	7.33e-05	0.00192	CbGpPWpGaD
Norfloxacin—CYP3A5—Biological oxidations—CYP1B1—ovarian cancer	7.33e-05	0.00192	CbGpPWpGaD
Norfloxacin—CYP3A5—Metapathway biotransformation—CYP1B1—ovarian cancer	7.23e-05	0.0019	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—TUBB3—ovarian cancer	7.18e-05	0.00188	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	7.12e-05	0.00187	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	7.06e-05	0.00185	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—ovarian cancer	7.03e-05	0.00184	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	6.98e-05	0.00183	CbGpPWpGaD
Norfloxacin—CYP1A1—Biological oxidations—CYP1B1—ovarian cancer	6.93e-05	0.00182	CbGpPWpGaD
Norfloxacin—CYP1A1—Metapathway biotransformation—CYP1B1—ovarian cancer	6.83e-05	0.00179	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CHEK2—ovarian cancer	6.71e-05	0.00176	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—ovarian cancer	6.66e-05	0.00175	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—PPP2R1A—ovarian cancer	6.63e-05	0.00174	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	6.6e-05	0.00173	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	6.5e-05	0.0017	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	6.47e-05	0.0017	CbGpPWpGaD
Norfloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	6.42e-05	0.00168	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	6.36e-05	0.00167	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	6.36e-05	0.00167	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	6.36e-05	0.00167	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	6.35e-05	0.00166	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	6.29e-05	0.00165	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CCND2—ovarian cancer	6.29e-05	0.00165	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—BRCA1—ovarian cancer	6.29e-05	0.00165	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	6.23e-05	0.00163	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—NME2—ovarian cancer	6.19e-05	0.00162	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CCNE1—ovarian cancer	6.16e-05	0.00162	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	6.13e-05	0.00161	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	6.07e-05	0.00159	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—ovarian cancer	6.05e-05	0.00159	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	6.01e-05	0.00158	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—PPP2R1A—ovarian cancer	5.93e-05	0.00156	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—PTEN—ovarian cancer	5.83e-05	0.00153	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—BRCA2—ovarian cancer	5.69e-05	0.00149	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—NME2—ovarian cancer	5.67e-05	0.00149	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CCNE1—ovarian cancer	5.51e-05	0.00144	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	5.49e-05	0.00144	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—ovarian cancer	5.44e-05	0.00143	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—ovarian cancer	5.42e-05	0.00142	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—ovarian cancer	5.42e-05	0.00142	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TYMS—ovarian cancer	5.41e-05	0.00142	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	5.34e-05	0.0014	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ovarian cancer	5.3e-05	0.00139	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	5.19e-05	0.00136	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	5.1e-05	0.00134	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	5.05e-05	0.00132	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	4.94e-05	0.0013	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	4.94e-05	0.0013	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—BIRC5—ovarian cancer	4.87e-05	0.00128	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.84e-05	0.00127	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	4.79e-05	0.00126	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TERT—ovarian cancer	4.71e-05	0.00124	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	4.66e-05	0.00122	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	4.63e-05	0.00121	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—ovarian cancer	4.5e-05	0.00118	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—NME2—ovarian cancer	4.47e-05	0.00117	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—ovarian cancer	4.45e-05	0.00117	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—CYP1B1—ovarian cancer	4.42e-05	0.00116	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—CYP1B1—ovarian cancer	4.36e-05	0.00114	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	4.28e-05	0.00112	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—NME2—ovarian cancer	4.22e-05	0.00111	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	4.15e-05	0.00109	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	4.14e-05	0.00109	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	4.05e-05	0.00106	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	4.05e-05	0.00106	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—ovarian cancer	4.05e-05	0.00106	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYTB—ovarian cancer	3.99e-05	0.00105	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—TP53—ovarian cancer	3.98e-05	0.00104	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	3.83e-05	0.001	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYTB—ovarian cancer	3.65e-05	0.000958	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	3.65e-05	0.000958	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—IL6—ovarian cancer	3.64e-05	0.000955	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	3.58e-05	0.00094	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	3.5e-05	0.000918	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—BRIP1—ovarian cancer	3.48e-05	0.000914	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PPP1CC—ovarian cancer	3.48e-05	0.000914	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	3.41e-05	0.000894	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	3.41e-05	0.000893	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	3.36e-05	0.000882	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	3.25e-05	0.000854	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—ovarian cancer	3.19e-05	0.000838	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PPP1CC—ovarian cancer	3.19e-05	0.000838	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—BRIP1—ovarian cancer	3.19e-05	0.000838	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—ovarian cancer	3.05e-05	0.000799	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.92e-05	0.000766	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYTB—ovarian cancer	2.88e-05	0.000756	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN1B—ovarian cancer	2.86e-05	0.000749	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CCND1—ovarian cancer	2.72e-05	0.000714	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYTB—ovarian cancer	2.72e-05	0.000714	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—NME2—ovarian cancer	2.69e-05	0.000706	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.66e-05	0.000698	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPP1CC—ovarian cancer	2.52e-05	0.000661	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—BRIP1—ovarian cancer	2.52e-05	0.000661	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—ovarian cancer	2.51e-05	0.000659	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—ovarian cancer	2.44e-05	0.000641	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—MAPK1—ovarian cancer	2.39e-05	0.000627	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPP1CC—ovarian cancer	2.38e-05	0.000624	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—BRIP1—ovarian cancer	2.38e-05	0.000624	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—YAP1—ovarian cancer	2.34e-05	0.000613	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.28e-05	0.000599	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MAPK3—ovarian cancer	2.25e-05	0.000589	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MYC—ovarian cancer	2.18e-05	0.000573	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—YAP1—ovarian cancer	2.14e-05	0.000562	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MAPK1—ovarian cancer	2.14e-05	0.000561	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—NME2—ovarian cancer	2.08e-05	0.000545	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—FASN—ovarian cancer	1.9e-05	0.0005	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—SLC5A5—ovarian cancer	1.87e-05	0.000491	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.86e-05	0.000489	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—SLC2A1—ovarian cancer	1.81e-05	0.000475	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TP53—ovarian cancer	1.79e-05	0.000471	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—FASN—ovarian cancer	1.75e-05	0.000458	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYTB—ovarian cancer	1.74e-05	0.000455	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP1B1—ovarian cancer	1.73e-05	0.000455	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.73e-05	0.000455	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—SLC5A5—ovarian cancer	1.72e-05	0.00045	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.7e-05	0.000445	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—YAP1—ovarian cancer	1.69e-05	0.000443	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—SLC2A1—ovarian cancer	1.66e-05	0.000435	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—YAP1—ovarian cancer	1.6e-05	0.000419	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP1B1—ovarian cancer	1.59e-05	0.000417	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.58e-05	0.000414	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	1.54e-05	0.000404	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—BRIP1—ovarian cancer	1.52e-05	0.000398	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPP1CC—ovarian cancer	1.52e-05	0.000398	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ABCB1—ovarian cancer	1.43e-05	0.000375	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PPP2R1A—ovarian cancer	1.41e-05	0.00037	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—TYMS—ovarian cancer	1.4e-05	0.000368	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.39e-05	0.000364	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—FASN—ovarian cancer	1.38e-05	0.000361	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.35e-05	0.000355	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYTB—ovarian cancer	1.34e-05	0.000351	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ABCB1—ovarian cancer	1.31e-05	0.000343	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—SLC2A1—ovarian cancer	1.31e-05	0.000343	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—FASN—ovarian cancer	1.3e-05	0.000341	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—TYMS—ovarian cancer	1.29e-05	0.000337	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SLC5A5—ovarian cancer	1.28e-05	0.000336	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP1B1—ovarian cancer	1.25e-05	0.000329	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—SLC2A1—ovarian cancer	1.24e-05	0.000324	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.21e-05	0.000317	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP1B1—ovarian cancer	1.18e-05	0.000311	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.17e-05	0.000307	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.17e-05	0.000307	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CAV1—ovarian cancer	1.13e-05	0.000297	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	1.11e-05	0.000292	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.11e-05	0.00029	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PPP2R1A—ovarian cancer	1.05e-05	0.000276	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.05e-05	0.000274	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CAV1—ovarian cancer	1.04e-05	0.000272	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ABCB1—ovarian cancer	1.03e-05	0.000271	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CG—ovarian cancer	1.03e-05	0.00027	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—YAP1—ovarian cancer	1.02e-05	0.000267	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—TYMS—ovarian cancer	1.01e-05	0.000266	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.01e-05	0.000264	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ABCB1—ovarian cancer	9.76e-06	0.000256	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—TYMS—ovarian cancer	9.58e-06	0.000251	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CG—ovarian cancer	9.44e-06	0.000248	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CD—ovarian cancer	9.05e-06	0.000237	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.85e-06	0.000232	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CD—ovarian cancer	8.3e-06	0.000218	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—FASN—ovarian cancer	8.29e-06	0.000218	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CAV1—ovarian cancer	8.17e-06	0.000214	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC5A5—ovarian cancer	8.16e-06	0.000214	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CB—ovarian cancer	7.89e-06	0.000207	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—SLC2A1—ovarian cancer	7.88e-06	0.000207	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—YAP1—ovarian cancer	7.85e-06	0.000206	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CAV1—ovarian cancer	7.72e-06	0.000203	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.72e-06	0.000202	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP1B1—ovarian cancer	7.55e-06	0.000198	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CG—ovarian cancer	7.44e-06	0.000195	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	7.38e-06	0.000193	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CB—ovarian cancer	7.23e-06	0.00019	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CG—ovarian cancer	7.03e-06	0.000184	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PTEN—ovarian cancer	6.82e-06	0.000179	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PPP2R1A—ovarian cancer	6.7e-06	0.000176	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.67e-06	0.000175	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CD—ovarian cancer	6.54e-06	0.000172	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—FASN—ovarian cancer	6.4e-06	0.000168	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC5A5—ovarian cancer	6.3e-06	0.000165	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PTEN—ovarian cancer	6.25e-06	0.000164	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ABCB1—ovarian cancer	6.22e-06	0.000163	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CD—ovarian cancer	6.18e-06	0.000162	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—TYMS—ovarian cancer	6.11e-06	0.00016	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—SLC2A1—ovarian cancer	6.08e-06	0.00016	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP1B1—ovarian cancer	5.83e-06	0.000153	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CB—ovarian cancer	5.7e-06	0.00015	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CB—ovarian cancer	5.39e-06	0.000141	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	5.17e-06	0.000136	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PTEN—ovarian cancer	4.93e-06	0.000129	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CAV1—ovarian cancer	4.92e-06	0.000129	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CA—ovarian cancer	4.81e-06	0.000126	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.8e-06	0.000126	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—TYMS—ovarian cancer	4.72e-06	0.000124	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.7e-06	0.000123	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PTEN—ovarian cancer	4.66e-06	0.000122	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CG—ovarian cancer	4.48e-06	0.000118	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CA—ovarian cancer	4.41e-06	0.000116	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CD—ovarian cancer	3.94e-06	0.000103	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—AKT1—ovarian cancer	3.93e-06	0.000103	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CAV1—ovarian cancer	3.8e-06	9.97e-05	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—AKT1—ovarian cancer	3.6e-06	9.45e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CA—ovarian cancer	3.48e-06	9.12e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.46e-06	9.08e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CB—ovarian cancer	3.44e-06	9.01e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CA—ovarian cancer	3.29e-06	8.62e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.04e-06	7.98e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PTEN—ovarian cancer	2.97e-06	7.79e-05	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—AKT1—ovarian cancer	2.84e-06	7.45e-05	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—AKT1—ovarian cancer	2.68e-06	7.04e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.65e-06	6.96e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PTEN—ovarian cancer	2.29e-06	6.01e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CA—ovarian cancer	2.09e-06	5.49e-05	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—AKT1—ovarian cancer	1.71e-06	4.49e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.62e-06	4.24e-05	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—AKT1—ovarian cancer	1.32e-06	3.46e-05	CbGpPWpGaD
